Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/26512
Title: | Prevention of Venous Thromboembolism in 2020 and Beyond |
Authors: | Nicholson M Chan N Bhagirath V Ginsberg J |
Keywords: | COVID;DVT;PE;VTE;cancer;epidemiology;prevention;prophylaxis |
Publication Date: | 1-Aug-2020 |
Publisher: | MDPI AG |
Abstract: | <jats:p>Venous thromboembolism (VTE) is the third most common cause of vascular mortality worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In this review, we discuss how an understanding of VTE epidemiology and the results of thromboprophylaxis trials have shaped the current approach to VTE prevention. We will discuss modern thromboprophylaxis as it pertains to genetic risk factors, exogenous hormonal therapies, pregnancy, surgery, medical hospitalization, cancer, and what is known thus far about VTE in COVID-19 infection.</jats:p> |
metadata.dc.rights.license: | Attribution - CC BY |
Rights: | Attribution - CC BY This Creative Commons license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. Recommended for maximum dissemination and use of licensed materials. |
URI: | http://hdl.handle.net/11375/26512 |
metadata.dc.identifier.doi: | https://doi.org/10.3390/jcm9082467 |
ISSN: | 2077-0383 2077-0383 |
Appears in Collections: | Faculty Publications (via McMaster Experts) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Prevention of Venous Thromboembolism in 2020 and Beyond.pdf | Published version | 732.91 kB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.